The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| AEGERION PHARMACEUTICALS INC | NOTE 5.000% 4/0 | 00767EAC6 | 2,844 | 2,993,334 | SH | SOLE | 2,993,334 | 0 | 0 | ||
| ACER THERAPEUTICS INC | COM | 00444P108 | 80 | 20,000 | SH | SOLE | 20,000 | 0 | 0 | ||
| ADAMAS PHARMACEUTICALS INC | COM | 00548A106 | 8,494 | 2,241,239 | SH | SOLE | 2,241,239 | 0 | 0 | ||
| AFFIMED NV | COM | N01045108 | 10,988 | 4,010,155 | SH | SOLE | 4,010,155 | 0 | 0 | ||
| AMARIN CORP PLC -ADR | SPONS ADR NEW | 023111206 | 33,260 | 1,551,300 | SH | SOLE | 1,551,300 | 0 | 0 | ||
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 4,706 | 1,651,333 | SH | SOLE | 1,651,333 | 0 | 0 | ||
| APTEVO THERAPEUTICS INC | COM | 03835L108 | 2,735 | 4,179,131 | SH | SOLE | 4,179,131 | 0 | 0 | ||
| CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 2,093 | 307,287 | SH | SOLE | 307,287 | 0 | 0 | ||
| CHIASMA INC | COM | 16706W102 | 911 | 183,660 | SH | SOLE | 183,660 | 0 | 0 | ||
| CUMBERLAND PHARMACEUTICALS | COM | 230770109 | 4,615 | 896,170 | SH | SOLE | 896,170 | 0 | 0 | ||
| CTI BIOPHARMA CORP | COM | 12648L601 | 5,933 | 3,755,000 | SH | SOLE | 3,755,000 | 0 | 0 | ||
| EVOLUS INC | COM | 30052C107 | 4,806 | 394,890 | SH | SOLE | 394,890 | 0 | 0 | ||
| HTG MOLECULAR DIAGNOSTICS | COM | 40434H104 | 3,340 | 4,758,426 | SH | SOLE | 4,758,426 | 0 | 0 | ||
| INTERPACE BIOSCIENCES INC | COM NEW | 46062X303 | 472 | 943,851 | SH | SOLE | 943,851 | 0 | 0 | ||
| IVERIC BIO INC | COM | 46583P102 | 25,740 | 3,000,000 | SH | SOLE | 3,000,000 | 0 | 0 | ||
| NEOS THERAPEUTICS INC | COM NEW | 64052L106 | 7,337 | 4,858,889 | SH | SOLE | 4,858,889 | 0 | 0 | ||
| NOVELION THERAPEUTICS INC | COM | 67001K202 | 2,759 | 3,909,207 | SH | SOLE | 3,909,207 | 0 | 0 | ||
| OPIANT PHARMACEUTICALS INC | COM | 683750103 | 4,814 | 334,272 | SH | SOLE | 334,272 | 0 | 0 | ||
| OXFORD IMMUNOTEC GLOBAL PLC | ORD SHS | G6855A103 | 10,472 | 630,862 | SH | SOLE | 630,862 | 0 | 0 | ||
| STRONGBRIDGE BIOPHARMA PLC | SHS USD | G85347105 | 903 | 431,853 | SH | SOLE | 431,853 | 0 | 0 | ||
| SCYNEXIS INC | COM | 811292101 | 555 | 609,384 | SH | SOLE | 609,384 | 0 | 0 | ||
| RESTORBIO INC | COM | 76133L103 | 122 | 81,772 | SH | SOLE | 81,772 | 0 | 0 | ||
| XOMA CORP | COM NEW | 98419J206 | 5,478 | 200,667 | SH | SOLE | 200,667 | 0 | 0 | ||